|
|
Article: S*BIO and National University Hospital-National University of Singapore Tissue Repository to Partner on Tumor Biomarker Research.
- Article from:
- PR Newswire
- Article date:
- May 29, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SINGAPORE, May 29 /PRNewswire/ -- S*BIO Pte Ltd, a privately held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer, has entered into a two-year research partnership with National University Hospital-National University of Singapore Tissue Repository (NUH-NUS TR). The company is partnering with Dr. Robert Hewitt, Director of the NUH-NUS TR, to conduct biomarker research and evaluate tumors' responsiveness to S*BIO's proprietary anti-cancer compounds.
"This partnership will allow us to better understand our compounds and their effects before being used in a clinical setting," said ...